In another research using murine models of colitis-associated CRC, berberine inhibited tumor growth and reduced Ki-67 expression, a marker of cell proliferation, while improving intestinal dysbiosis by increasing Akkermansia, Lactobacillus, and Bacteroides and modulating tryptophan metabolism and Wnt signaling pathways [60]. Here, MKI67 is linked to colitis.